15-89294945-T-G

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BS1BS2

The NM_001113378.2(FANCI):​c.2487T>G​(p.Leu829Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00178 in 1,552,344 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0016 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0018 ( 10 hom. )

Consequence

FANCI
NM_001113378.2 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:11

Conservation

PhyloP100: 0.986

Publications

1 publications found
Variant links:
Genes affected
FANCI (HGNC:25568): (FA complementation group I) The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group I. Alternative splicing results in two transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]
FANCI Gene-Disease associations (from GenCC):
  • Fanconi anemia complementation group I
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P
  • Fanconi anemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).
BP6
Variant 15-89294945-T-G is Benign according to our data. Variant chr15-89294945-T-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 210986.
BP7
Synonymous conserved (PhyloP=0.986 with no splicing effect.
BS1
Variant frequency is greater than expected in population mid. GnomAdExome4 allele frequency = 0.0018 (2517/1400038) while in subpopulation MID AF = 0.0205 (117/5702). AF 95% confidence interval is 0.0175. There are 10 homozygotes in GnomAdExome4. There are 1314 alleles in the male GnomAdExome4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 10 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001113378.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FANCI
NM_001113378.2
MANE Select
c.2487T>Gp.Leu829Leu
synonymous
Exon 24 of 38NP_001106849.1
FANCI
NM_001376911.1
c.2487T>Gp.Leu829Leu
synonymous
Exon 24 of 38NP_001363840.1
FANCI
NM_001376910.1
c.2208T>Gp.Leu736Leu
synonymous
Exon 24 of 38NP_001363839.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FANCI
ENST00000310775.12
TSL:1 MANE Select
c.2487T>Gp.Leu829Leu
synonymous
Exon 24 of 38ENSP00000310842.8
FANCI
ENST00000674831.1
c.2487T>Gp.Leu829Leu
synonymous
Exon 24 of 39ENSP00000502474.1
FANCI
ENST00000696719.1
c.2487T>Gp.Leu829Leu
synonymous
Exon 25 of 39ENSP00000512832.1

Frequencies

GnomAD3 genomes
AF:
0.00162
AC:
246
AN:
152188
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000965
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00255
Gnomad ASJ
AF:
0.00605
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000830
Gnomad FIN
AF:
0.00104
Gnomad MID
AF:
0.0222
Gnomad NFE
AF:
0.00225
Gnomad OTH
AF:
0.00336
GnomAD2 exomes
AF:
0.00210
AC:
333
AN:
158914
AF XY:
0.00216
show subpopulations
Gnomad AFR exome
AF:
0.000240
Gnomad AMR exome
AF:
0.00234
Gnomad ASJ exome
AF:
0.00386
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00105
Gnomad NFE exome
AF:
0.00266
Gnomad OTH exome
AF:
0.00752
GnomAD4 exome
AF:
0.00180
AC:
2517
AN:
1400038
Hom.:
10
Cov.:
31
AF XY:
0.00190
AC XY:
1314
AN XY:
690490
show subpopulations
African (AFR)
AF:
0.000791
AC:
25
AN:
31598
American (AMR)
AF:
0.00353
AC:
126
AN:
35706
Ashkenazi Jewish (ASJ)
AF:
0.00349
AC:
88
AN:
25182
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35738
South Asian (SAS)
AF:
0.000984
AC:
78
AN:
79230
European-Finnish (FIN)
AF:
0.000827
AC:
41
AN:
49582
Middle Eastern (MID)
AF:
0.0205
AC:
117
AN:
5702
European-Non Finnish (NFE)
AF:
0.00173
AC:
1869
AN:
1079104
Other (OTH)
AF:
0.00297
AC:
173
AN:
58196
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
119
239
358
478
597
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
66
132
198
264
330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00160
AC:
244
AN:
152306
Hom.:
0
Cov.:
32
AF XY:
0.00164
AC XY:
122
AN XY:
74472
show subpopulations
African (AFR)
AF:
0.0000962
AC:
4
AN:
41574
American (AMR)
AF:
0.00255
AC:
39
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00605
AC:
21
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.000831
AC:
4
AN:
4816
European-Finnish (FIN)
AF:
0.00104
AC:
11
AN:
10622
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.00225
AC:
153
AN:
68030
Other (OTH)
AF:
0.00332
AC:
7
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
13
26
38
51
64
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00215
Hom.:
1
Bravo
AF:
0.00186
Asia WGS
AF:
0.00115
AC:
4
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:11
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:4
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Sep 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

FANCI: BP4, BP7

Fanconi anemia complementation group I Uncertain:1Benign:2
Mar 18, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease.

Fanconi anemia Benign:2
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jun 30, 2021
Sema4, Sema4
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:curation

not specified Benign:1
May 26, 2021
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Hereditary cancer-predisposing syndrome Benign:1
Sep 17, 2024
Molecular Diagnostics Laboratory, Catalan Institute of Oncology
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

BP4, BP7 c.2487T>G located in exon 24 of the FANCI gene is predicted to result in no amino acid change, p.(Leu829=)(BP7).This variant is found in 183/73958, with a filter allele frequency of 0.25% at 99% confidence in the gnomAD v2.1.1 database (European non-Finnish non-cancer data set). The SpliceAI algorithm predicts no significant impact on splicing (BP4). In addition, the variant was also identified in the ClinVar database (3x benign, 6x likely benign, 1x uncertain significance). To our knowledge, neither clinical data nor functional studies have been reported for this variant. Based on currently available information, the variant c.2487T>G is classified as a likely benign variant according to ACMG guidelines.

FANCI-related disorder Benign:1
Feb 17, 2020
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.48
CADD
Benign
9.1
DANN
Benign
0.78
PhyloP100
0.99
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs145762491; hg19: chr15-89838176; COSMIC: COSV55522771; COSMIC: COSV55522771; API